Continuous positive airway pressure therapy and cardiovascular outcomes in obstructive sleep apnoea syndrome: where are we now?

Obstructive sleep apnoea syndrome (OSA) is highly prevalent with recent epidemiological reports indicating prevalence for moderate or severe sleep disordered breathing (SDB) of up to 50% in the general male population, although the prevalence of a clinically significant syndrome is considerably less (1,2).